Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107
Article
PubMed
Google Scholar
Villanueva A, Minguez B, Forner A, Reig M, Llovet JM (2010) Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med 61:317–328. doi:10.1146/annurev.med.080608.100623
Article
CAS
PubMed Central
PubMed
Google Scholar
Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7(8):448–458. doi:10.1038/nrgastro.2010.100
Article
PubMed Central
PubMed
Google Scholar
Yau T, Chan P, Epstein R, Poon RT (2008) Evolution of systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol WJG 14(42):6437–6441
Article
PubMed
Google Scholar
Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, Bae HI et al (2011) Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol 103(2):148–151. doi:10.1002/jso.21786
Article
PubMed
Google Scholar
Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO et al (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132(7):2542–2556. doi:10.1053/j.gastro.2007.04.025
Article
CAS
PubMed
Google Scholar
Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK et al (2008) Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47(3):919–928. doi:10.1002/hep.22082
Article
CAS
PubMed
Google Scholar
Yin S, Li J, Hu C, Chen X, Yao M, Yan M et al (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer J Int du Cancer 120(7):1444–1450. doi:10.1002/ijc.22476
Article
CAS
Google Scholar
Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD (2014) Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J Gastroenterol WJG 20(8):2098–2106. doi:10.3748/wjg.v20.i8.2098
Article
PubMed
Google Scholar
Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY (2008) CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27(12):1749–1758. doi:10.1038/sj.onc.1210811
Article
CAS
PubMed
Google Scholar
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P et al (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13(2):153–166. doi:10.1016/j.ccr.2008.01.013
Article
CAS
PubMed
Google Scholar
Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H et al (2008) EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68(5):1451–1461. doi:10.1158/0008-5472.CAN-07-6013
Article
CAS
PubMed
Google Scholar
Li J, Yu Y, Wang J, Yan Z, Liu H, Wang Y et al (2015) Establishment of a novel system for the culture and expansion of hepatic stem-like cancer cells. Cancer Lett 360(2):177–186. doi:10.1016/j.canlet.2015.02.006
Article
CAS
PubMed
Google Scholar
Grigoryev YA, Kurian SM, Hart T, Nakorchevsky AA, Chen C, Campbell D et al (2011) MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol 187(5):2233–2243. doi:10.4049/jimmunol.1101233
Article
CAS
PubMed Central
PubMed
Google Scholar
Szeto CY, Lin CH, Choi SC, Yip TT, Ngan RK, Tsao GS et al (2014) Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems. FEBS Open Bio 4:128–140. doi:10.1016/j.fob.2014.01.004
Article
CAS
PubMed Central
PubMed
Google Scholar
Zhang W, Zang J, Jing X, Sun Z, Yan W, Yang D et al (2014) Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer. J Trans Med 12:66. doi:10.1186/1479-5876-12-66
Article
Google Scholar
Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5(7):621–628. doi:10.1038/nmeth.1226
Article
CAS
PubMed
Google Scholar
Li R, Li Y, Kristiansen K, Wang J (2008) SOAP: short oligonucleotide alignment program. Bioinformatics 24(5):713–714. doi:10.1093/bioinformatics/btn025
Article
CAS
PubMed
Google Scholar
Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39(Database issue):D152–D157. doi:10.1093/nar/gkq1027
Article
CAS
PubMed Central
PubMed
Google Scholar
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19(2):232–243. doi:10.1016/j.ccr.2011.01.001
Article
CAS
PubMed
Google Scholar
Barrera-Figueroa BE, Gao L, Diop NN, Wu Z, Ehlers JD, Roberts PA et al (2011) Identification and comparative analysis of drought-associated microRNAs in two cowpea genotypes. BMC Plant Biol 11:127. doi:10.1186/1471-2229-11-127
Article
CAS
PubMed Central
PubMed
Google Scholar
Gonzalez-Ballester D, Casero D, Cokus S, Pellegrini M, Merchant SS, Grossman AR (2010) RNA-seq analysis of sulfur-deprived Chlamydomonas cells reveals aspects of acclimation critical for cell survival. Plant Cell 22(6):2058–2084. doi:10.1105/tpc.109.071167
Article
CAS
PubMed Central
PubMed
Google Scholar
Audic S, Claverie JM (1997) The significance of digital gene expression profiles. Genome Res 7(10):986–995
CAS
PubMed
Google Scholar
Benjamini YH, Yosef Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B 57(1):289–300
Google Scholar
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic acids research. 34(Database issue):D140–D144. doi:10.1093/nar/gkj112
Article
CAS
PubMed Central
PubMed
Google Scholar
Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, Mourelatos Z et al (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18(10):1165–1178. doi:10.1101/gad.1184704
Article
CAS
PubMed Central
PubMed
Google Scholar
John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2(11):e363. doi:10.1371/journal.pbio.0020363
Article
PubMed Central
PubMed
Google Scholar
Wang X (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14(6):1012–1017. doi:10.1261/rna.965408
Article
CAS
PubMed Central
PubMed
Google Scholar
Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al (2005) Combinatorial microRNA target predictions. Nat Genet 37(5):495–500. doi:10.1038/ng1536
Article
CAS
PubMed
Google Scholar
Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39(10):1278–1284. doi:10.1038/ng2135
Article
CAS
PubMed
Google Scholar
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15–20. doi:10.1016/j.cell.2004.12.035
Article
CAS
PubMed
Google Scholar
Fisher RA (1992) On the interpretation of χ2 from contingency tables, and the calculation of P. J Roy Stat Soc 85(1):87–94
Article
Google Scholar
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3(6):453–458. doi:10.1038/nrc1098
Article
CAS
PubMed
Google Scholar
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563–572. doi:10.1038/nrc865
Article
CAS
PubMed
Google Scholar
Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48(4):1312–1327. doi:10.1002/hep.22506
Article
CAS
PubMed Central
PubMed
Google Scholar
Ashour AE, Abd-Allah AR, Korashy HM, Attia SM, Alzahrani AZ, Saquib Q et al (2014) Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis. Mol Cell Biochem 389(1–2):85–98. doi:10.1007/s11010-013-1930-1
Article
CAS
PubMed
Google Scholar
Cui XD, Lee MJ, Yu GR, Kim IH, Yu HC, Song EY et al (2010) EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma. Int J Cancer J Int du Cancer 126(4):940–949. doi:10.1002/ijc.24798
CAS
Google Scholar
Yeh YT, Lee KT, Tsai CJ, Chen YJ, Wang SN (2012) Prolactin promotes hepatocellular carcinoma through Janus kinase 2. World J Surg 36(5):1128–1135. doi:10.1007/s00268-012-1505-4
Article
PubMed
Google Scholar
Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY et al (2002) Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 169(2):1102–1109
Article
CAS
PubMed
Google Scholar
Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4(1):11–22. doi:10.1038/nrc1252
Article
CAS
PubMed
Google Scholar
Yamaguchi H, Condeelis J (2007) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773(5):642–652. doi:10.1016/j.bbamcr.2006.07.001
Article
CAS
PubMed Central
PubMed
Google Scholar
Golubovskaya VM, Cance W (2010) Focal adhesion kinase and p53 signal transduction pathways in cancer. Front Biosci (Landmark Ed) 15:901–912
Article
CAS
Google Scholar
Zhao J, Guan JL (2009) Signal transduction by focal adhesion kinase in cancer. Cancer metastasis reviews. 28(1–2):35–49. doi:10.1007/s10555-008-9165-4
Article
PubMed
Google Scholar
Klagsbrun M, Eichmann A (2005) A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16(4–5):535–548. doi:10.1016/j.cytogfr.2005.05.002
Article
CAS
PubMed
Google Scholar
Sun G, Shan MH, Ma BL, Geng ZL, Alibiyati A, Zhong H et al (2012) Identifying crosstalk of mTOR signaling pathway of lobular breast carcinomas. Eur Rev Med Pharmacol Sci 16(10):1355–1361
CAS
PubMed
Google Scholar